Narendra D. Lalwani

Overview

Narendra D. Lalwani received an average of $2M in total compensation, including $303K in salary, at Esperion Therapeutics from 2014 to 2016.

Source: SEC filing on March 6, 2017.

Related executives

We found 11 more executives who work or worked at Esperion Therapeutics.

Sheldon Koenig

Esperion Therapeutics

Chief Executive Officer

JoAnne Foody

Esperion Therapeutics

Chief Medical Officer

Eric Warren

Esperion Therapeutics

Chief Commercial Officer

Benjamin Looker

Esperion Therapeutics

General Counsel

Tim Mayleben

Esperion Therapeutics

Chief Executive Officer

Richard Bartram

Esperion Therapeutics

Chief Financial Officer

Ashley Hall

Esperion Therapeutics

Former Chief Development Officer

Mark Glickman

Esperion Therapeutics

Chief Commercial Officer

You may also like